The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
AGILE THERAPEUTICS INC. | COM NEW | 00847L209 | 20,183 | 87,754 | SH | SOLE | 87,754 | 0 | 0 | ||
MICRON TECHNOLOGY INC | COM | 595112103 | 412,335 | 8,250 | SH | SOLE | 8,250 | 0 | 0 | ||
NASDAQ INC | COM | 631103108 | 3,569,491,835 | 58,182,426 | SH | SOLE | 58,182,426 | 0 | 0 | ||
STANLEY BLACK & DECKER, INC. | COM | 854502101 | 428,184 | 5,700 | SH | SOLE | 5,700 | 0 | 0 | ||
WEWORK | CL A | 96209A104 | 324,809 | 227,139 | SH | SOLE | 227,139 | 0 | 0 |